8 results
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... 100 mg PO once daily ... mucoadhesive buccal tablet ... chew, or crush tablet ... candida #mucosal #IDSA
IDSA Algorithm for the Initial Management of Fever and Neutropenia

LOW RISK
 • Antidpated neutropenia < 7
IDSA Algorithm for ... and clinically stable ... neutropenic #fever #IDSA ... #Algorithm #Management
CA-Bridge Buprenorphine Hospital Quick Start Algorithm - Management of acute opiate withdrawal 
 - Any prescriber
Hospital Quick Start Algorithm ... If patient is stable ... Total initial daily ... Buprenorphine #Treatment #Algorithm
IDSA Algorithm for Neutropenic Fever - Initial Management, Subsequent Management and Prolonged Fever
Figure 1. Initial management
IDSA Algorithm for ... and clinically stable ... neutropenic #fever #IDSA ... #Algorithm #Management
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
IDSA Recommendations ... Rifabutin 300 mg PO daily ... please refer to Table ... 500 mg PO twice daily ... AviumComplex #MAC #IDSA
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... 200 mg PO once daily ... at 3 mg/kg IV daily ... with ARV (see Table ... Histoplasmosis #IDSA
IDSA Recommended Dosages of Antimicrobial Agents Administered by the Intraventricular Route
Amikacin - 5–50 mg
Amphotericin B -
IDSA Recommended ... 24 hours: once daily ... and give once daily ... ventriculitis #table ... #idsa
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... INH 300 mg PO daily ... RIF 600 mg PO daily ... Please refer to the table ... Tuberculosis #TB #IDSA